Injunctive Relief:
Fitletic shall not sell the Covered Product in its current formulation for
distribution in California in the future, and shall not resume sales of the Covered Product
in California unless the product meets the reformulation standard set forth in Paragraph
3.2.
3.2. Upon the Effective Date, Fitletic agrees to only manufacture for sale or purchase
for sale in or into California, “Reformulated Covered Products.” For purposes of this
Settlement Agreement, “Reformulated Covered Products” are Covered Products
containing no more than 1,000 parts per million (0.1%) DEHP in any accessible
component (i.e., any component that may be touched during use). In order to determine
compliance with this reformulation standard, Fitletic may rely on third party testing from
an accredited laboratory.